Company description

Neopharma, UAE’s premier pharmaceutical manufacturing company commenced operations in 2003 with the vision to locally manufacture world class pharmaceuticals at affordable prices. From a single manufacturing unit, Neopharma today has become a global pharmaceutical company supported by 8 manufacturing facilities spread across 3 continents delivering branded and generic formulations, and active pharmaceutical ingredients (APIs). The product portfolio covers 100 high-quality molecules in 9 therapy areas including anti-infectives, neurology, cardiology, orthopedics, diabetology, gastroenterology, urology, dermatology, gynecology, respiratory, dental and nutritionals. Driven by innovation, Neopharma lays strong emphasis on research, especially towards development of processes and products that are patent non-infringing. Neopharma currently caters to over 50 international markets including Middle East, Africa, CIS, USA and South East Asia. 

For further information, please visit www.neopharma.com

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: APIs |Intermediates, Fine and Specialty Chemicals |Finished Dosage Forms More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 41K11 See our Exhibitor Profile   See full Exhibitor List
16 sep 2019

CPHI Middle East & Africa 2019

16 -18 September 2019 ADNEC, Abu Dhabi, UAE We were at stand M40 See our Exhibitor Profile   See full Exhibitor List

Contact information




View all contact information